• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

指导方针方法在保护处于依赖关系中的患者自愿知情同意方面的优势和劣势。

Strengths and weaknesses of guideline approaches to safeguard voluntary informed consent of patients within a dependent relationship.

机构信息

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.

出版信息

BMC Med. 2014 Mar 24;12:52. doi: 10.1186/1741-7015-12-52.

DOI:10.1186/1741-7015-12-52
PMID:24655604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3998040/
Abstract

BACKGROUND

It is thought that a dependent relationship between patients and physicians who enroll their own patients in research compromises voluntary informed consent. Therefore, several ethical guidelines for human subject research provide approaches to mitigate these compromises. Currently, these approaches have not been critically evaluated. In this article, we analyze the approaches of ethical guidelines to manage the influence of a dependent relationship between patients and physicians on voluntary informed consent and discuss the strengths and weaknesses of these approaches.

METHODS

We performed a review of international ethical guidance documents on human subject research, listed in the Oxford Textbook of Clinical Research Ethics and found through cross referencing. We also searched Global Ethics Observatory (GEObs) and the World Health Organization (WHO) website. Guidelines from all years were eligible for inclusion. The date last searched was December 2013.

DISCUSSION

We identified two basic guideline approaches: 1. A process approach, which focuses on the person who obtains informed consent, that is, an independent individual, such as a research nurse or counselor; and 2. A content approach, emphasizing the voluntary nature of participation. Both approaches are valuable, either because the influence of the physician may diminish or because it empowers patients to make voluntary decisions. However, the approaches also face challenges. First, research nurses are not always independent. Second, physician-investigators will be informed about decisions of their patients. Third, involvement of a counselor is sometimes unfeasible. Fourth, the right to withdraw may be difficult to act upon in a dependent relationship.

CONCLUSIONS

Current guideline approaches to protect voluntary informed consent within a dependent relationship are suboptimal. To prevent compromises to voluntary informed consent, consent should not only be obtained by an independent individual, but this person should also emphasize the voluntary nature of participation. At the same time, dependency as such does not imply undue influence. Sometimes the physician may be best qualified to provide information, for example, for a very specialized study. Still, the research nurse should obtain informed consent. In addition, patients should be able to consult a counselor, who attends the informed consent discussions and is concerned with their interests. Finally, both physicians and research nurses should disclose research interests.

摘要

背景

人们认为,患者和参与研究的医生之间的从属关系会影响到患者自愿知情同意的达成。因此,一些人类受试者研究的伦理准则提供了减轻这些影响的方法。目前,这些方法尚未经过严格评估。在本文中,我们分析了伦理准则处理患者和医生之间从属关系对自愿知情同意影响的方法,并讨论了这些方法的优缺点。

方法

我们对牛津临床研究伦理教科书和交叉引用列出的国际人类受试者研究伦理指南进行了审查,并在全球伦理观察站(GEObs)和世界卫生组织(WHO)网站上进行了搜索。所有年份的指南都符合纳入标准。最后一次搜索日期为 2013 年 12 月。

讨论

我们确定了两种基本的准则方法:1. 一种是关注获取知情同意的人,即研究护士或顾问等独立个体的过程方法;2. 另一种是强调参与的自愿性的内容方法。这两种方法都有价值,因为医生的影响可能会减弱,或者因为它使患者能够做出自愿的决定。然而,这些方法也面临挑战。首先,研究护士并不总是独立的。其次,医师研究者将了解其患者的决定。第三,顾问的参与有时是不可行的。第四,在从属关系中,退出的权利可能难以行使。

结论

目前保护从属关系下自愿知情同意的准则方法并不理想。为了防止对自愿知情同意的影响,同意不仅应由独立的个人获得,而且该人还应强调参与的自愿性。同时,从属关系本身并不意味着不当影响。有时,医生可能是提供信息的最佳人选,例如对于非常专业的研究。然而,研究护士仍应获得知情同意。此外,患者应该能够咨询顾问,顾问参加知情同意讨论并关注他们的利益。最后,医生和研究护士都应披露研究利益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7553/3998040/6a5003c4c18d/1741-7015-12-52-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7553/3998040/6a5003c4c18d/1741-7015-12-52-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7553/3998040/6a5003c4c18d/1741-7015-12-52-1.jpg

相似文献

1
Strengths and weaknesses of guideline approaches to safeguard voluntary informed consent of patients within a dependent relationship.指导方针方法在保护处于依赖关系中的患者自愿知情同意方面的优势和劣势。
BMC Med. 2014 Mar 24;12:52. doi: 10.1186/1741-7015-12-52.
2
A Qualitative Study into Dependent Relationships and Voluntary Informed Consent for Research in Pediatric Oncology.一项关于儿童肿瘤学研究中依赖关系与自愿知情同意的定性研究。
Paediatr Drugs. 2016 Apr;18(2):145-56. doi: 10.1007/s40272-015-0158-9.
3
[The origin of informed consent].[知情同意的起源]
Acta Otorhinolaryngol Ital. 2005 Oct;25(5):312-27.
4
When Is It Ethical for Physician-Investigators to Seek Consent From Their Own Patients?医生-研究者何时从自己的患者那里寻求同意是合乎道德的?
Am J Bioeth. 2019 Apr;19(4):11-18. doi: 10.1080/15265161.2019.1572811.
5
[The process of consent in clinical trials: from elaboration to accomplishment].[临床试验中的同意过程:从拟定到完成]
Arq Bras Oftalmol. 2005 Sep-Oct;68(5):704-7. doi: 10.1590/s0004-27492005000500026. Epub 2005 Nov 28.
6
[Informed consent: going through the motions?].[知情同意:只是走过场?]
Harefuah. 2014 Feb;153(2):115-8, 125.
7
Re-evaluating ethical concerns in planned emergency research involving critically ill patients: an interpretation of the guidance document from the United States Food and Drug Administration.重新评估涉及重症患者的计划性紧急研究中的伦理问题:对美国食品药品监督管理局指导文件的解读
J Clin Ethics. 2015 Spring;26(1):61-7.
8
Analysis of the compliance of informed consent documents with good clinical practice guideline.知情同意文件符合良好临床实践规范的分析。
Contemp Clin Trials. 2011 Sep;32(5):662-6. doi: 10.1016/j.cct.2011.05.016. Epub 2011 Jun 2.
9
Bioethics committees and examining consent within the patient-physician relationship in Turkey.土耳其的生物伦理委员会与医患关系中的知情同意审查
Med Law. 2010 Sep;29(3):403-18.
10
Proposing modesty for informed consent.提出适度的知情同意。
Soc Sci Med. 2007 Dec;65(11):2284-95. doi: 10.1016/j.socscimed.2007.08.006. Epub 2007 Sep 19.

引用本文的文献

1
Clinicians' experiences of obtaining informed consent for research and treatment: a nested qualitative study from Pakistan.临床医生在研究和治疗中获取知情同意的经验:来自巴基斯坦的嵌套定性研究。
BMC Med Ethics. 2024 Nov 15;25(1):131. doi: 10.1186/s12910-024-01119-8.
2
Voluntariness of consent in paediatric HIV clinical trials: a mixed-methods, cross-sectional study of participants in the CHAPAS-4 and ODYSSEY trials in Uganda.儿科艾滋病毒临床试验中同意的自愿性:对乌干达CHAPAS - 4和奥德赛试验参与者的混合方法横断面研究
BMJ Open. 2024 Mar 1;14(3):e077546. doi: 10.1136/bmjopen-2023-077546.
3
Physician-Investigator, Research Coordinator, and Patient Perspectives on Dual-Role Consent in Oncology: A Qualitative Study.

本文引用的文献

1
The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research.《贝尔蒙报告》。保护人类研究受试者的伦理原则与准则。
J Am Coll Dent. 2014 Summer;81(3):4-13.
2
World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.《世界医学协会赫尔辛基宣言:涉及人类受试者的医学研究伦理原则》
JAMA. 2013 Nov 27;310(20):2191-4. doi: 10.1001/jama.2013.281053.
3
Recruitment to clinical trials: a meta-ethnographic synthesis of studies of reasons for participation.
医师-研究者、研究协调员和患者对肿瘤学中双重角色同意的观点:一项定性研究。
JAMA Netw Open. 2023 Jul 3;6(7):e2325477. doi: 10.1001/jamanetworkopen.2023.25477.
4
Community engagement: health research through informing, consultation, involving and empowerment in Ingwavuma community.社区参与:通过信息、咨询、参与和赋权,在 Ingwavuma 社区开展健康研究。
Front Public Health. 2023 Jun 2;11:1050589. doi: 10.3389/fpubh.2023.1050589. eCollection 2023.
5
Gurus and Griots: Revisiting the research informed consent process in rural African contexts.导师与吟游诗人:在非洲农村背景下重新审视以研究为基础的知情同意过程。
BMC Med Ethics. 2021 Jul 23;22(1):98. doi: 10.1186/s12910-021-00659-7.
6
A CTSA One Health Alliance guidance on institutional review of veterinary clinical studies.CTSA 一 项关于兽医临床研究机构审查的联盟指南。
BMC Vet Res. 2021 Feb 17;17(1):83. doi: 10.1186/s12917-021-02790-4.
7
Informed consent for neonatal trials: practical points to consider and a check list.新生儿试验的知情同意:需考虑的实际要点及清单
BMJ Paediatr Open. 2020 Dec 29;4(1):e000847. doi: 10.1136/bmjpo-2020-000847. eCollection 2020.
8
Understanding the child-doctor relationship in research participation: a qualitative study.理解研究参与中的儿童-医生关系:一项定性研究。
BMC Pediatr. 2020 Jul 24;20(1):353. doi: 10.1186/s12887-020-02243-1.
9
Pioneering Informed Consent for Return of Research Results to Breast Cancer Patients Facing Barriers to Implementation of Genomic Medicine: The Kenyan BRCA1/2 Testing Experience Using Whole Exome Sequencing.为面临基因组医学实施障碍的乳腺癌患者返还研究结果的开创性知情同意:肯尼亚使用全外显子测序进行BRCA1/2检测的经验
Front Genet. 2020 Mar 6;11:170. doi: 10.3389/fgene.2020.00170. eCollection 2020.
10
Ethical considerations of researchers conducting pediatric clinical drug trials: a qualitative survey in two Belgian university children's hospitals.研究者开展儿科临床药物试验的伦理考量:在比利时两所大学儿童医院开展的定性调查。
Eur J Pediatr. 2018 Jul;177(7):1003-1008. doi: 10.1007/s00431-018-3151-9. Epub 2018 Apr 21.
招募临床试验参与者:对参与原因的研究的元民族志综合分析。
J Health Serv Res Policy. 2013 Oct;18(4):233-41. doi: 10.1177/1355819613483126. Epub 2013 Aug 28.
4
Not the usual suspects: addressing layers of vulnerability.非惯常嫌疑人:解决多层次的脆弱性。
Bioethics. 2013 Jul;27(6):325-32. doi: 10.1111/bioe.12035. Epub 2013 May 30.
5
Vulnerability in research ethics: a way forward.研究伦理中的漏洞:前进之路。
Bioethics. 2013 Jul;27(6):333-40. doi: 10.1111/bioe.12032. Epub 2013 May 30.
6
Physician recruitment of patients to non-therapeutic oncology clinical trials: ethics revisited.招募患者参加非治疗性肿瘤临床试验的医师:重新审视伦理学问题。
Front Pharmacol. 2013 Mar 11;4:25. doi: 10.3389/fphar.2013.00025. eCollection 2013.
7
Assessing whether consent for a clinical trial is voluntary.评估一项临床试验的同意是否是自愿给出的。
Ann Intern Med. 2013 Feb 5;158(3):222-4. doi: 10.7326/0003-4819-158-3-201302050-00025.
8
Recruiting terminally ill patients into non-therapeutic oncology studies: views of health professionals.招募绝症患者参加非治疗性肿瘤学研究:卫生专业人员的观点。
BMC Med Ethics. 2012 Dec 5;13:33. doi: 10.1186/1472-6939-13-33.
9
Shared decision-making: enhancing the clinical relevance.共同决策:增强临床相关性。
J R Soc Med. 2012 Oct;105(10):416-21. doi: 10.1258/jrsm.2012.120039.
10
Supporting positive experiences and sustained participation in clinical trials: looking beyond information provision.支持积极的体验和持续参与临床试验:超越信息提供。
J Med Ethics. 2012 Dec;38(12):751-6. doi: 10.1136/medethics-2011-100059. Epub 2012 Aug 8.